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Abstract The modular evolutionary origin of NADH:ubiqui-
none oxidoreductase (complex I) provides useful insights into its
functional organization. Iron^sulfur cluster N2 and the PSST
and 49 kDa subunits were identi¢ed as key players in ubiqui-
none reduction and proton pumping. Structural studies indicate
that this ‘catalytic core’ region of complex I is clearly separated
from the membrane. Complex I from Escherichia coli and Kleb-
siella pneumoniae was shown to pump sodium ions rather than
protons. These new insights into structure and function of com-
plex I strongly suggest that proton or sodium pumping in com-
plex I is achieved by conformational energy transfer rather than
by a directly linked redox pump.
/ 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Complex I (reduced nicotinamide adenine dinucleotide
(NADH):ubiquinone oxidoreductase) is the last ‘terra incog-
nita’ among the respiratory chain complexes. Despite contin-
uous e¡orts to understand its structure and function over the
last ¢ve decades, even fundamental issues remain unsolved.
This is in stark contrast to the growing interest in complex
I due to its role in the generation of reactive oxygen species [1]
and the increasing number of diseases that are caused by or
related to complex I defects [2]. For a number of reasons,
complex I is much more di⁄cult to study than other respira-
tory chain complexes: Consisting of up to 45 di¡erent sub-
units and a total mass of almost 1000 kDa, mitochondrial
complex I is one of the biggest and most complicated known
membrane protein complexes. With 14 subunits and some 500
kDa, the prokaryotic counterpart is still rather big and com-
plex. Moreover, the bacterial enzymes tend to be extremely
unstable. So far complex I from Escherichia coli and the
closely related Klebsiella pneumoniae are the only bacterial
enzymes that could be puri¢ed in intact form [3,4].
Complex I is the only respiratory chain complex for which
no X-ray structure is available so far. Iron^sulfur clusters, the
prominent prosthetic groups of complex I, have no character-
istic spectra in the visible region. Therefore, electron para-
magnetic resonance (EPR) spectroscopy at very low temper-
atures has to be used, but this technique cannot be applied to
rapid kinetics and requires large amounts of sample. Also
structure/function studies based on the analysis of mutants
are scarce for complex I: Even in E. coli mutagenesis of com-
plex I is not a trivial task, as all structural genes are expressed
and controlled by a single operon. For a long time mitochon-
drial complex I was studied primarily from bovine heart or
from the ¢lamentous fungus Neurospora crassa. While genetic
manipulation of the mammalian enzyme is virtually impossi-
ble, even in N. crassa the introduction of site directed mutants
is rather tedious. To overcome this limitation we recently in-
troduced Yarrowia lipolytica as a model organism to study
complex I [5]. For the ¢rst time, this strictly aerobic yeast
allows e⁄cient genetic manipulation of the nuclear coded sub-
units of mitochondrial complex I. Moreover a his-tagged ver-
sion of complex I can be puri¢ed rapidly and with high yield
from Y. lipolytica [6].
Numerous hypothetical mechanisms have been proposed
over the years (see [7] for an overview). Here we compile
the available evidence on structure and function of complex
I and use the resulting constraints to narrow in on the com-
ponents of the proton/sodium pumping machinery and the
way they may operate.
2. Subunit composition and evolutionary origin
Eukaryotic complex I contains a total number of more than
35 subunits in fungi [8] and at least 45 subunits in mammals
[9,10]. 14 of these subunits (Table 1) are also present in the
minimal forms of complex I found in bacteria like E. coli,
Thermus thermophilus, Paracoccus denitri¢cans and Rhodo-
bacter capsulatus [11]. In eukaryotes, seven of the 14 ‘central’
subunits are nuclear coded and contain all known redox pros-
thetic groups, namely one molecule of £avin adenine mono-
nucleotide (FMN) and eight to nine iron^sulfur clusters (see
below). The remaining seven ‘ND’ subunits are highly hydro-
phobic proteins with several putative transmembrane helices
and are encoded by the mitochondrial genome in most eu-
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Table 1
Central subunits of complex I and homologies to subunits of other bacterial enzymes
Complex I subunit symbol Redox prosthetic
groups
Fragments or
sub-complexes
Homologous subunits in related enzymes
Bovine Y. lipolytica E. coli E. coli Bovine NADþ reducing
hydrogenase
A. eutrophus/formate
dehydrogenase
M. formicicum
Water soluble [NiFe]
hydrogenase e.g.
D. fructosovorans
Membrane bound
type-3 hydrogenase
(FHL-1) E. coli/(Ech)
M. barkeri
Membrane bound
type-4 hydrogenase
(FHL-2) E. coli
Antiporter e.g.
B. subtilis
75 kDa NUAM NuoG N1b, N1c, N4, N5 DF IV HoxU/FdhA ^ ^ ^ ^
51 kDa NUBM NuoF FMN, N3 DF IV, FP HoxF ^ ^ ^ ^
49 kDa NUCM NuoDa ^ CF IV ^ large subunit EchE/HycE HyfG ^
30 kDa NUGM NuoCa ^ CF IV ^ ^ EchD/HycE HyfG ^
24 kDa NUHM NuoE N1a DF IV, FP HoxF ^ ^ ^ ^
TYKY NUIM NuoI N6a, N6b HF IV ^ ^ EchF/HycF HyfH ^
PSST NUKM NuoB N2 HF IV ^ small subunit EchC/HycG HyfI ^
ND1 ND1 NuoH ^ MF IQ ^ ^ EchB/HycD HyfC ^
ND2 ND2 NuoN ^ MF IQ ^ ^ EchAb/HycCb HyfB,D,Fb MrpDb
ND3 ND3 NuoA ^ MF IQ ^ ^ ^ ^ ^
ND4 ND4 NuoM ^ MF IL ^ ^ EchAb/HycCb HyfB,D,Fb MrpDb
ND4L ND4L NuoK ^ MF IQ ^ ^ ^ HyfE? ^
ND5 ND5 NuoL ^ MF IL ^ ^ EchAb/HycCb HyfB,D,Fb MrpAb
ND6 ND6 NuoJ ^ MF ^ ^ ^ ^ ^ ^
Abbreviations: DF, dehydrogenase fragment; CF, connecting fragment; MF, membrane fragment; FP, £avoprotein.
aIn E. coli both subunits are fused (NuoCD).
bThe ND2, 4 and 5 subunits are weakly homologous to each other, an assignment of the individual subunits to other proteins is ambiguous.
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karyotes (Table 1). Very little is known about the function of
the remaining up to 31 ‘accessory’ subunits.
It has been proposed that complex I was assembled from
preexisting modules during evolution [12,13] and it can be
expected that these modules form structural units in complex
I (Table 1). The homology to hydrogenases has been espe-
cially useful for the understanding of complex I: The 49 kDa
subunit and the PSST subunit are homologous to the large
and small subunits of soluble [NiFe] hydrogenases. Membrane
bound type-3 hydrogenases like the enzyme encoded by the
hyc operon in E. coli or the ech operon in Methanosarcina
barkeri contain additional proteins that are homologous to
complex I subunits. In addition to the 49 kDa and PSST
subunits, these are the 30 kDa, TYKY, ND1 subunits and
one more hydrophobic subunit which could be homologous
to either ND2, ND4 or ND5. The latter three proteins are
weakly related to each other and show sequence similarities to
Naþ/Hþ antiporters of the type encoded by the mrp operon in
Bacillus subtilis and the corresponding mnh operon in Staph-
ylococcus aureus [14,15].
In E. coli another type of hydrogenase was described that is
related to complex I: Type-4 hydrogenase is encoded by the
hyf operon [16] and contains the same homologs to complex I
genes already found in type-3 hydrogenases. However, it com-
prises two more proteins of the Naþ/Hþ or Kþ/Hþ antiporter,
ND2/ND4/ND5 superfamily and a hydrophobic protein that
exhibits some similarity to ND4L in its C-terminal half [13]. It
is remarkable that only formate hydrogenlyase 2, the combi-
nation of formate dehydrogenase and type-4 hydrogenase is
driven by an electrochemical proton gradient, while formate
hydrogenlyase 1, the combination of formate dehydrogenase
and type-3 hydrogenase is not [17].
The electron input domain of complex I is related to the
oxidized nicotinamide adenine dinucleotide (NADþ) reducing
hydrogenase from Alcaligenes eutrophus [18]. The 24 and
51 kDa subunits are homologous to HoxF and the ¢rst 200
residues of the 75 kDa subunit are homologous to HoxU.
HoxF and HoxU together form the NADH oxidoreductase
part of the enzyme. It was suggested that the 75 kDa subunit
is a fusion of two proteins of di¡erent origin because the
C-terminal half shows sequence similarity to a formate dehy-
drogenase from Methanobacterium formicicum [13].
There are two more gene fusions in complex I and related
enzymes that further support the view of a modular origin of
complex I. In complex I from E. coli and in the corresponding
subunits of the hyc and hyf operon the C-terminus of the
30 kDa subunit is fused with the N-terminus of the 49 kDa
subunit. In the F420 reducing hydrogenase from Archaeoglobus
fulgidus the subunits corresponding to the PSST and 30 kDa
subunits are fused [19].
3. Redox groups
Complex I contains one non-covalently bound FMN and
various iron^sulfur clusters as redox active groups [20,21] (Ta-
ble 1). FMN (midpoint potential at pH 7.5 (Em;7:5) =3336
mV) is the entry point for electrons from NADH. Due to
the relative stability of the semi£avin (Kstab = 3.4U1032 at
pH 7) FMN functions as electron converter between the
n=2 electron donor NADH and the n=1 electron transfer-
ring iron^sulfur clusters [22]. EPR spectroscopy of the £avin
radical generated by reduction of complex I revealed an un-
usually broad line width of 2.4 mT and large spin relaxation
enhancement. Both e¡ects are explained by strong spin^spin
interaction of the semi£avin with iron^sulfur cluster N3 which
shows a concomitant broadening of its EPR spectrum [22]. In
line with this interpretation, disruption of the gene encoding
the NADH binding 51 kDa subunit in N. crassa resulted in
the loss of FMN and iron^sulfur cluster N3 [23].
Depending on the origin of the enzyme, di¡erent numbers
of iron^sulfur clusters have been identi¢ed. In the reduced
form, these clusters possess paramagnetic S=1/2 ground
states. At very low temperatures, this property allows appli-
cation of EPR spectroscopy, the main experimental approach
to study the iron^sulfur clusters of complex I. The well-char-
acterized enzyme of bovine heart mitochondria contains six
EPR detectable iron^sulfur clusters designated N1a and N1b,
N2, N3, N4, N5 according to their increasing spin relaxation
rates [20]. In E. coli complex I eight clusters were identi¢ed
and designated N1a, N1b, N1c, N2, N3, N4, N6a, and N6b
[3,24,25]. In the yeast Y. lipolytica ¢ve clusters, N1, N2, N3,
N4, N5 [8] and in N. crassa only four clusters, N1, N2, N3,
N4 [26] could be identi¢ed by EPR spectroscopy so far. Bi-
nuclear (Fe2S2) and tetranuclear (Fe4S4) iron^sulfur clusters
were found in complex I: Owing to their slower spin relaxa-
tion rates Fe2S2 clusters can be detected at somewhat higher
temperatures (s 30 K) than Fe4S4 clusters (6 20 K).
3.1. Fe2S2 clusters
N1a is bound to the 24 kDa subunit [27,28]. In bovine
complex I, this cluster has the lowest redox midpoint potential
(Em;7 =3370 mV) and exhibits a pH dependence of 360 mV/
pH [29,30]. Analysis of the isolated 24 kDa subunit from
bovine mitochondria and di¡erent bacteria by protein-¢lm
voltammetry revealed that at low ionic strength the reduction
potential changes only byV100 mV between pH 5 and 9 [31].
This pH dependence resulted from pH linked changes in pro-
tein charge, rather than from coupling to a speci¢c ionizable
residue. Although the 24 kDa subunit is present and the pre-
sumed liganding residues are conserved in Y. lipolytica and
N. crassa, N1a is not detectable in complex I from these
organisms by EPR spectroscopy. An extremely negative redox
potential preventing reduction by NADH or an unusual spin
state or magnetic interaction could render iron^sulfur cluster
N1a EPR silent in these organisms. Cluster N1b could be
assigned to the 75 kDa subunit [28]. According to its Em;7
of about 3250 mV it is, together with N3, N4, N5, one of
the so called isopotential iron^sulfur clusters [20,30].
A third binuclear cluster, N1c, was ¢rst described for com-
plex I from E. coli [3]. The 75 kDa subunit of E. coli contains
an additional unique cysteine binding motif which seems to
bind iron^sulfur cluster N1c [24]. This motif is also present in
T. thermophilus [32]. Overexpression of this subunit, reconsti-
tution and spectroscopic characterization revealed that this
extra binding motif most likely harbors a Fe4S4 rather than
a Fe2S2 cluster [33].
3.2. Fe4S4 clusters
Iron^sulfur cluster N2 has very distinct properties and
therefore has been singled out from the other ‘isopotential’
clusters. There has been an intense controversy in recent years
about the question which subunit ligates iron^sulfur cluster
N2. While Albracht and colleagues still consider the TYKY
subunit as the most likely candidate [34], there is now good
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evidence suggesting that cluster N2 is bound to the PSST
subunit [35^37] and resides at the interface between the
PSST and the 49 kDa subunits [38] (see below). Because of
its relatively high redox midpoint potential (Em;7 =3150 mV)
and an EPR detectable magnetic interaction with semiquinone
(SQ) radicals (see below) it is generally assumed that this
redox center is the immediate electron donor for ubiquinone
[20,39].
A redox midpoint potential dependence of 360 mV/pH unit
around neutral pH values reported for bovine complex I [29]
has been considered as an indication that cluster N2 may be
directly involved in the proton translocation mechanism [7].
However, this attractive option seems unlikely now: For
Y. lipolytica complex I we have determined a pKox of V6
and a pKred of V7 for the protonable group associated
with iron^sulfur cluster N2. Around neutral pH this results
in a slope for the pH dependent redox midpoint potential
change of less than 40 mV/pH (Zwicker et al., in preparation).
As already mentioned, cluster N3 is located in the 51 kDa
subunit [23,40] forming an electron input device together
with FMN.
Cluster N4 resides in the 75 kDa subunit [28]. In addition
to the binding motifs for clusters N1b and N4 there is a third
motif in this subunit which has been proposed to ligate an
additional tetranuclear cluster, N5 [20,30]. So far this cluster
could only be detected in complex I from bovine heart mito-
chondria, R. sphaeroides [30] and Y. lipolytica [8]. Cluster N5
has a very high spin relaxation rate and a low spin concen-
tration which makes EPR spectroscopic analysis rather di⁄-
cult. A very low redox potential or magnetic interaction with
another paramagnetic center may be the reason for the appar-
ent sub-stoichiometric spin concentration of cluster N5.
Two conserved ferredoxin type binding motifs for iron^sul-
fur clusters could be identi¢ed in the sequence of the TYKY
subunit. It was shown by ultraviolet visible (UV/Vis) spectros-
copy that TYKY contains two additional Fe4S4 clusters that
are not detectable by standard EPR spectroscopy. These clus-
ters have been named N6a and N6b and seem to be arranged
like in 8Fe-ferredoxins [35,41]. Although alternate stoichiom-
etries have been proposed [42], binding motifs, protein chem-
ical characterization, cofactor content and spectroscopic data
overall strongly suggest that complex I contains one of each
iron^sulfur cluster per FMN [3,5,20,26].
4. Semiquinones
During steady state NADH oxidation ubisemiquinone rad-
icals could be identi¢ed in submitochondrial particles (SMP)
from bovine heart by various groups using EPR spectroscopic
approaches [20,43^46]. T. Ohnishi and coworkers identi¢ed
three types of SQ species (SQNf , SQslow, SQNx) that contribute
to the low temperature EPR signals (40 K, g=2.004) in tightly
coupled SMP. These di¡er in their spin relaxation properties,
electrochemical potential di¡erence for protons (vWHþ ) depen-
dence, temperature dependence and inhibitor sensitivity [47].
The fast relaxing SQNf is only detectable in tightly coupled
SMP (respiratory control ratio s 5) and is sensitive to pier-
icidin A and rotenone. In contrast, SQslow is also detectable
in uncoupled SMP and its rotenone sensitivity is less pro-
nounced. However, its piericidin A sensitivity is the same as
for SQNf .
The unusual temperature dependence and the high spin
relaxation rate of the SQNf EPR signal indicate a magnetic
interaction with a nearby paramagnetic center. A possible
candidate is cluster N2. Its EPR signal shows splitting, or at
least signi¢cant broadening, in the gz region under conditions
generating the SQNf radical. Assuming a dipole^dipole inter-
action, a distance of 8^11 AV was calculated between cluster
N2 and SQNf [44]. Nearly the same distance (11 AV ) was ob-
tained by simulating the enhancement of the half saturation
parameter of SQNf based on the assumption that this e¡ect
results from an interaction with cluster N2 [47]. The EPR
signal arising from SQslow follows the Curie law suggesting
that this radical is at least 30 AV away from any other para-
magnetic center. The third radical species, SQNx, which also
exhibits vWHþ independence, features a very low spin relaxa-
tion rate and contributes to about 35% of the total free radical
signal (SQNf : 50%, SQslow : 15%) in coupled SMP [47]. This
radical was not yet characterized in more detail. So far, com-
plex I associated SQ were observed only in SMP from bovine
heart and not in membrane preparations from bacteria or
fungi.
5. Inhibitors
More than 60 di¡erent families of compounds (of natural
and synthetic origin) are known to inhibit complex I [48,49].
Insect and ¢sh mitochondria are particularly sensitive to com-
plex I inhibition, which explains the traditional use of rote-
none derivatives as ¢sh and insect poison. Another important
and highly speci¢c group of natural complex I inhibitors are
the piericidins. A number of synthetic insecticides/acaricides
have complex I as their target [50] and can be grouped into
two main classes: (i) pyrazoles and substituted pyrimidines,
(ii) pyridines and quinazolines. Prominent examples of these
two classes are fenpyroximate and DQA (2-decyl-4-quinazo-
linyl amine, formerly known as SAN 548A), respectively.
Most complex I inhibitors are hydrophobic or amphipathic
compounds. Therefore, it was inferred that many of them may
act as ubiquinone antagonists. Kinetic studies suggested that
these inhibitors can be grouped into three classes represented
by piericidin A and DQA (class I/A-type), rotenone (class II/
B-type) and capsaicin (C-type) [51,52]. The demonstration of
two independent binding sites for hydrophobic inhibitors had
been a key experiment to demonstrate that a proton motive
Q-cycle was operating in the cytochrome bc1 complex [53].
Therefore, the three classes of complex I inhibitors stimulated
discussions whether the pumping mechanism in complex I
may be based on a reversed version of the Q-cycle and several
hypothetical mechanistic schemes were proposed [7,54]. How-
ever, direct competition experiments with inhibitors from dif-
ferent classes revealed that they all share one common binding
domain with partially overlapping sites [55]. In agreement
with this observation, inhibitor resistant mutants of complex
I in R. capsulatus [56,57] and Y. lipolytica [58] exhibit cross
resistance between class I/A-type and class II/B-type inhibi-
tors. The emerging picture is that one large amphipathic bind-
ing pocket accepts a plethora of chemically di¡erent com-
pounds including even polyoxyethylene type detergents like
Triton X-100 and Thesit [21]. Although this has not been
demonstrated directly, it seems very likely that this pocket
also comprises the ubiquinone binding site(s) of complex I.
Domains from several subunits seem to form this binding
pocket. Inhibitor resistant mutants were found primarily in
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the 49 kDa subunit [56^58], but some point mutations in the
PSST homologous subunit of Y. lipolytica exhibit altered in-
hibitor sensitivities as well [37]. Inhibitor binding to PSST
was also demonstrated by photoa⁄nity labeling with a pyri-
daben derivative [59]. In this study rather unspeci¢c labeling
of the ND1 subunit was observed as well, like in earlier pho-
toa⁄nity labeling studies with a rotenone derivative [60]. Very
recently, a photoa⁄nity analog of fenpyroximate was re-
ported to bind covalently to the ND5 subunit of complex I
from bovine heart mitochondria [61]. Remarkably, pathogenic
mutations were not only identi¢ed in mitochondrially coded
subunits but also in the 49 kDa subunit [62] and the PSST
subunit [63].
6. The ‘catalytic core’
The essence of the functional studies reviewed so far is that
in particular those subunits seem to be involved in ubiquinone
reduction that was derived from the catalytic subunits of
[NiFe] hydrogenases: The PSST subunit, the homolog of the
small subunit of hydrogenase, was shown to carry iron^sulfur
cluster N2, the probable immediate electron donor for ubiqui-
none; inhibitor resistant mutations were found in the 49 kDa
subunit, the homolog of the large subunit of hydrogenase. To
further explore this evolutionary link and to get insight into
complex I function, we reasoned that the X-ray structures of
water soluble, two-subunit [NiFe] hydrogenases [64^66] may
be useful as a model for the ubiquinone reactive ‘catalytic
core’ of complex I. A ¢rst important clue in this direction
came from the observation that three of the four cysteine li-
gands of the [NiFe] cluster in water soluble hydrogenases
correspond to conserved residues in complex I: One cysteine
has been replaced by the conserved valine that was identi¢ed
as the target of the ¢rst randomly selected inhibitor resistant
mutation of R. capsulatus [56]. Two other cysteine ligands
have been replaced by conserved acidic residues in complex
I. Site directed mutagenesis in Y. lipolytica of all three amino
acids resulted in inhibitor resistance [58].
Inspection of the alignment of four loops of the D. fructo-
sovorans [NiFe] hydrogenase that are in close contact to the
[NiFe] site with the homologous regions of the 49 kDa sub-
unit revealed a number of amino acids that are fully conserved
even between these two rather distant enzyme families. Two of
these loops contain a pair of cysteine ligands each (C72/C75
and C543/C546). One loop is bounded by conserved glycines
and carries a highly conserved histidine (H228) at its tip. The
Fig. 1. Schematic view of conserved residues in the catalytic core region of complex I. The amino acid stretches from the 49 kDa subunit of
Y. lipolytica complex I corresponding to the four loops that surround the [NiFe] site in water soluble hydrogenases are shown. Secondary struc-
ture elements and positions of metal ions were taken from the structure of the D. fructosovorans enzyme (PBD ¢le 1FRF). Positions that are
identical in complex I from Y. lipolytica, N. crassa, B. taurus, R. capsulatus are marked in light yellow, residues that are in addition conserved
in E. coli are in light green, residues conserved between Y. lipolytica complex I and the D. fructosovorans hydrogenase are marked in dark
green. Residues that correspond to the cysteine ligands in the hydrogenase are circled in orange. Iron^sulfur cluster N2 and the surface of the
NUKM subunit (the PSST homolog) are indicated.
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fourth loop contains a conserved proline (P475). Analysis of
site directed mutants in these conserved regions (Fig. 1) re-
sulted in speci¢c changes of complex I activity, inhibitor sen-
sitivity and the EPR signal of cluster N2 consistent with their
position predicted from the structure of [NiFe] hydrogenase
[58] : Mutations predicted to be closer to the former [NiFe]
site tend to a¡ect inhibitor binding. Mutations predicted to be
closer to the former proximal iron^sulfur cluster in the small
subunit of [NiFe] hydrogenases tend to a¡ect the EPR line
shape of iron^sulfur cluster N2. These ¢ndings support the
following concept: (i) The structural fold of [NiFe] hydroge-
nases has been retained in complex I. (ii) Cluster N2 corre-
sponds to the proximal iron^sulfur cluster of hydrogenases
and is located at the interface between the 49 kDa and the
PSST subunits. However, the identity of the fourth ligand of
iron^sulfur cluster N2 remains unclear, because one cysteine
ligand of the proximal cluster in hydrogenase is not conserved
in the PSST subunit. It is tempting to speculate that this
fourth ligand may reside on the 49 kDa subunit of complex
I. (iii) A signi¢cant part of the quinone binding pocket of
complex I is located within the 49 kDa subunit and has di-
rectly evolved from the [NiFe] site of hydrogenases.
7. Structural organization
To date there is no detailed structural information available
for complex I. Electron microscopic analysis of single particles
and two-dimensional (2D) crystals has been carried out with
complex I from bovine heart [67,68], the ¢lamentous fungus
N. crassa [69^72], the aerobic yeast Y. lipolytica [8] and the
bacteria E. coli [72] and Aquifex aeolicus [73]. In all these
studies an L shaped overall structure was observed with a
membrane arm and a perpendicular peripheral arm protrud-
ing into the mitochondrial matrix or the bacterial cytoplasm.
Recently, induction of a novel ‘horse-shoe’ conformation of
the E. coli complex I was described under conditions of zero
ionic strength [74]. However, the relevance of this observation
is still unclear as induction of this alternate shape could not be
reproduced in another laboratory working with the same or-
ganism [75].
A gross assignment of subunits to the two arms and their
mutual structural interaction (see Table 1 and Fig. 2) can be
based on (i) the dual genetic control of complex I by the
mitochondrial and nuclear genome, (ii) the characterization
of sub-complexes, and (iii) modules of common evolutionary
origin: in higher eukaryotes seven hydrophobic subunits are
encoded by the mitochondrial genome. In N. crassa grown in
the presence of chloramphenicol, an inhibitor of mitochon-
drial protein synthesis, a small form of complex I is formed
which consists of hydrophilic, nuclear encoded proteins only.
The hydrophobic and hydrophilic parts of the enzyme could
be analyzed separately by electron microscopy of 2D crystals
allowing an assignment of the two di¡erent arms observed in
the complete enzyme [70]. Di¡erent fragments and sub-com-
plexes have been generated by dissociation of the puri¢ed
complex I. From E. coli a fragment containing the 75, 51,
and 24 kDa subunits can be generated [3]. Treatment of bo-
vine complex I with chaotropes releases the so called £avo-
protein (FP) [76] which contains the 51, 24 and 10 kDa sub-
units. This fragment represents the electron input part of the
Fig. 2. Cartoon of the approximate positions of central subunits and iron^sulfur clusters within L shaped complex I. The binding sites of anti-
bodies recognizing the 49 kDa subunit (*) and the 30 kDa subunit (#) are indicated. There is no evidence available for the arrangement of the
other subunits in the peripheral arm which is oriented perpendicular to the membrane and protrudes into the mitochondrial matrix. The mem-
brane arm consists of seven highly hydrophobic subunits (ND1^ND6 and ND4L). In eukaryotic complex I a substantial number of accessory
subunits is found which are not indicated in the ¢gure. The subunit symbol is given in red and redox groups in the complex are denoted in
black. The hypothetical sequence of electron transfer steps from NADH to ubiquinone (Q) is indicated by small black arrows.
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enzyme and transfers electrons from NADH to arti¢cial ac-
ceptors like ferricyanide or hexaamineruthenium [77].
Complex I from bovine heart can be fractionated by su-
crose gradient centrifugation [78] or ion exchange chroma-
tography [79,80] in the presence of LDAO (lauryl-N,N-di-
methylamine-N-oxide). A number of sub-complexes have
been described and we focus here on IV, IL and IQ (Table 1).
Sub-complex IV as described in [78] contains hydrophilic sub-
units and presumably comprises the major part of the periph-
eral arm. Sub-complexes IL and IQ together contain all of the
hydrophobic ND subunits except ND6. It was inferred that in
the membrane part of complex I the ND4 and ND5 subunits
on one hand and the ND1 and ND2 subunits on the other
hand are next to each other [80]. Electron microscopic anal-
ysis of 2D crystals suggested that subunit ND5 is localized at
the distal end of the membrane arm [67]. Sub-complex IQ
contains subunits ND1 and ND2 and has been proposed to
reside near the junction of the membrane and peripheral arms.
Overall the next neighbor relationships for the central sub-
units of complex I obtained from biochemical and electron
microscopic characterization ¢t with the evolutionary origin
of the di¡erent parts of complex I discussed above.
A more precise localization of subunits has been achieved
by electron microscopy of immunolabeled complex I (Zicker-
mann et al., submitted): the position of the C-terminus of the
30 kDa subunit and two N-terminal epitopes of the 49 kDa
subunit could be identi¢ed in 2D averages of Y. lipolytica
complex I single particles decorated with monoclonal antibod-
ies (Fig. 2). As one of the epitopes was found near the tip of
the peripheral arm, it is obvious that the 49 kDa subunit and
thus the ‘catalytic core’ of complex I must be clearly separated
from the membrane arm of complex I. Remarkably, the hy-
drophobic ND2, ND4 and ND5 subunits seem to contain
rather large hydrophilic domains that could connect the 49
kDa and PSST subunits to the membrane arm [14,81]. Fig.
2 summarizes the structural organization of complex I that
can be deduced by combining all available evidence.
8. Proton/sodium pumping mechanism
Our knowledge about structure and function of complex I
is still very limited. Therefore, any discussion about the mech-
anism how this respiratory chain complex uses redox energy
to transport charges across the membrane is restricted. It can
only analyze whether a given hypothetical concept is compat-
ible with the constraints that are imposed by the available
evidence. Thus hypothetical mechanisms are useful, if they
make testable predictions. Over the years many proposals
have been made regarding how mitochondrial complex I
might pump protons. These can be subdivided into three basic
types of mechanism: (i) directly redox linked proton pumps;
(ii) redox linked ligand conduction mechanisms; (iii) confor-
mational energy transfer. Examples for all three mechanisms
can be found in oxidative phosphorylation: Cytochrome c
oxidase is a directly linked proton pump [82], the proton
motive Q-cycle of the cytochrome bc1 complex is a ligand
conduction mechanism [83] and adenosine triphosphate
(ATP) synthase makes ATP by conformational energy trans-
fer [84]. In theory, the large number of redox prosthetic
groups, some of which have a pH dependent midpoint poten-
tial, allows for a great variety of possible mechanistic scenar-
ios for a directly linked proton pump (see [7] for an overview).
In essence all such mechanisms imply that electron transfer
is directly translated into vectorial charge translocation. In
most simple terms, this can be envisioned as a redox group
within the membrane dielectric that takes up a proton from
one side of the membrane upon reduction and releases it in a
gated fashion to the other side upon reoxidation. However, as
more and more information on the structural organization of
complex I became available, it became clear that all known
redox centers reside in the peripheral arm. Still, the observa-
tion that the stability of a SQ species near iron^sulfur cluster
N2 was dependent on the membrane potential [47] seemed to
suggest that this redox center was close to the membrane
domain. Therefore, it seemed feasible that iron^sulfur cluster
N2 was a component of a proton pump [20].
In a ligand conduction mechanism like the Q-cycle, charge
is at least partly translocated across the membrane as elec-
trons. This is translated into a proton gradient by electron
transfer between two active sites and redox linked protonation
and deprotonation of a suitable substrate like ubiquinone (the
‘ligand’) on opposite sides of the membrane. To account for a
stoichiometry of 4 Hþ/2e3 mechanistic schemes were pro-
posed in recent years that combined features of a direct
pump with a reversed Q-cycle type mechanism [7,54]. How-
ever, recent evidence seems to exclude these hypothetical
mechanisms like all other concepts involving directly linked
pumps: Reverse Q-cycle schemes became unlikely, as the dif-
ferent classes of complex I inhibitors turned out to bind to the
same large binding pocket [55].
It was shown by Steuber and colleagues that complex I
from K. pneumonia and E. coli pumps sodium ions rather
than protons [15]. As direct pumping mechanisms are essen-
tially operating through redox linked pKA changes, it is di⁄-
cult though not impossible that the same charge compensation
mechanisms would be possible with sodium ions. As the stoi-
chiometry is only 2 Naþ/2e3 it has been discussed that these
complexes employ a completely di¡erent mechanism. How-
ever, as evident from the example of ATP synthase, conforma-
tional energy transfer mechanisms can be essentially the same
for protons and sodium ions [85]. Finally, our recent ¢nding
that the 49 kDa subunit and thus the ‘catalytic core’ compris-
ing the critical iron^sulfur cluster N2 is clearly separated from
the membrane (Zickermann et al., submitted) places the site of
ubiquinone reduction into the hydrophilic domain. As the SQ
that can be detected at a distance of about 10 AV from iron^
sulfur cluster N2 [47] strongly suggests that this redox center
is in fact the immediate electron donor for ubiquinone, one
has to assume that the ubiquinone headgroup can somehow
reach up into the peripheral arm. This would ¢t with the
concept of a large and rather unspeci¢c inhibitor binding
pocket that could provide an amphipathic ‘ramp’ guiding ubi-
quinone from the membrane domain into its catalytic site near
the interface of the 49 kDa and PSST subunit.
Stimulated by the observation of redox dependent changes
in cross linking patterns between subunits of the peripheral
arm, a proton pumping mechanism reminiscent of the confor-
mationally linked mechanism of ATP synthase has been pro-
posed a long time ago [86]. However, only now one has to
conclude mainly because evidence excludes other options that
an indirect mechanism of proton and sodium pumping via
long range conformational energy transfer is operating in
complex I. At this point the most likely scenario is that the
redox chemistry of ubiquinone reduction around iron^sulfur
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cluster N2 induces speci¢c conformational changes. These
changes are then transmitted to the hydrophobic subunits in
the membrane that have been derived from Naþ/Hþ or Kþ/
Hþ antiporters and act as ion pumps.
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